Discover Accurate and Flexible Prostate Cancer Risk Prediction.

Now Available for At-Home Sample Collection.

This non-DRE urine test delivers best-in-class precision in identifying patients at low risk for clinically significant prostate cancer, supporting informed decisions. It’s available for both at-home and in-office collection.

Client Services:
(888) 978-8677
8 a.m.-8 p.m. ET
Monday-Friday

Live Chat
Chat with our Client Services team.

Learn More

Trusted by providers. No DRE required.

Let’s explore how MyProstateScore 2.0 fits into your practice and elevate your approach to PSA risk stratification.

Complete the form to connect with a Lynx Dx representative, who will:

review performance data
help set up your provider account
and guide you through the steps to begin offering MyProstateScore 2.0.

"*" indicates required fields

First Name*

Last Name*

Email*

Phone

I am a:*

Provider

Patient/Caregiver

Other

State

I'm inquiring about:

Ordering MyProstateScore 2.0

Product Questions

General Inquiries

Comments

I have not shared any personal healthcare data

Acceptance Terms

By checking this box, I agree to receive relevant marketing communications regarding products, industry news, literature, and events from Lynx Dx. I understand that I can change my preferences by contacting client services. I further understand that any data provided to Lynx Dx will be stored, used, and deleted consistent with our Privacy Policy.

This field is hidden when viewing the form

utm_campaign__c

This field is hidden when viewing the form

utm_medium__c

This field is hidden when viewing the form

utm_source__c

This field is hidden when viewing the form

GCLID__c

MyProstateScore 2.0 (MPS2)

MyProstateScore 2.0 (MPS2) was built on a cohort-specific algorithm to optimize diagnostic accuracy and provide validated and objective performance for patients considering an initial or repeat prostate biopsy.

Its 18 biomarkers are the most comprehensive and demonstrate the most extensive performance characteristics of any test on the market, with the option to enhance the analysis with clinical factors.

With the new flexibility to collect samples at home, MPS2 fits seamlessly into your workflow while enhancing patient experience.